Related references
Note: Only part of the references are listed.Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer
Feng Wang-Johanning et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Human ERV3-1 env protein expression in various human tissues and tumours
Yun-Jeong Kang et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Expression and regulation of the endogenous retrovirus 3 in Hodgkin's lymphoma cells
Stefanie Kewitz et al.
FRONTIERS IN ONCOLOGY (2013)
Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors
Feng Wang-Johanning et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma
Darko Gosenca et al.
PLOS ONE (2012)
Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability
Silvia Hahn et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer
Rafael Contreras-Galindo et al.
JOURNAL OF VIROLOGY (2008)
Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer
Feng Wang-Johanning et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): Implications for present-day activity
R Belshaw et al.
JOURNAL OF VIROLOGY (2005)
Long-term reinfection of the human genome by endogenous retroviruses
R Belshaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
